TheDaoIndex KDAO2011
2 years 8 months ago
ICYMI There are 2022 Guidelines for exercise rehab and diet for patients with #RheumatoidArthritis
found here https://t.co/PWjPHGqqeM
#RNL2024 @RheumNow
TheDaoIndex KDAO2011
2 years 8 months ago
#Cardiorheumatology is an emerging, important field; contact Dr. Weber if interested in learning more. #RNL2024 @Rheumnow https://t.co/WhMlC7AtHU
Eric Dein ericdeinmd
2 years 8 months ago
#RNL2024
@RheumNow
ASCVD Risk Calculators underestimate risk in patients of RA
Inflammatory disease was added as a "risk enhancer" in 2019 update
"A low ASCVD and/or absence of symptoms may be not be reassuring" https://t.co/XjTuzvvO4v
Dr. Rachel Tate uptoTate
2 years 8 months ago
Why is improved plaque identification important?
1. Most stress tests are normal!
2. Most events occur in pts with normal function studies
3. Plaque burden predicts risk, better than stenosis
Dr. B. Weber #RNL2024 @RheumNow https://t.co/Qs19qIYj5v
TheDaoIndex KDAO2011
2 years 8 months ago
ICYMI: new guidelines published in 2019 for CV prevention. It's important to assess CV risk in our patients because inflammatory diseases is now included as a risk factor (helps when deciding on starting pts on JAKi)- Dr. B Weber #RNL2024 @RheumNow https://t.co/nBQjs49avu https://t.co/apyDjaxudi
Dr. Rachel Tate uptoTate
2 years 8 months ago
Primary ASCVD Prevention Guidelines for your reference from Dr. B. Weber. #RNL2024 @RheumNow https://t.co/erxIgeeLNU
Dr. Rachel Tate uptoTate
2 years 8 months ago
Dr. B. Weber's review of the 2019 ASCVD risk factors which now includes inflammatory diseases (RA, HIV, PsO).
She believes this will help us to better understand and grow our knowledge around patient risk. @RheumNow #RNL2024 https://t.co/9bV7VfExNf
TheDaoIndex KDAO2011
2 years 8 months ago
Nuclear imaging assesses cardiac function, anatomy & microvascular dysfunction (MD). MD is underrecognized but can be measured by coronary flow reserve. MD is associated with worse longterm outcomes in systemic inflammatory disease – Dr. Weber #RNL2024 @rheumnow https://t.co/Bv22UKi6mM
Dr. Rachel Tate uptoTate
2 years 8 months ago
Coronary Microvascular Dysfunction is associated with poor prognosis/outcomes in our systemic inflammatory disease patients.
What is the gold standard for evaluating microvascular dysfunction?
Coronary Flow Reserve (CRF)
This is only one component to fully understand and assess… https://t.co/bMV5npkFwm https://t.co/ZYBXpQLPIF
Dr. Antoni Chan synovialjoints
2 years 8 months ago
Link between inflammation and cardiovascular disease, increased 1.5x in RA and 2-3 in PsA, treating inflammation is important to reduce CV risk, Brittany Weber #RNL2024 @RheumNow https://t.co/FCrOxa3drZ
Dr. Rachel Tate uptoTate
2 years 8 months ago
Dr. B Weber gave a wonderful review of inflammation and cardiac risk in SLE, PsO/PsA, and RA.
*SLE pts has a 50-fold increased risk of MI
*RA pts are a 1.5x risk of CVD
*PsO and PsA pts are also at increased risk for CVD
#RNL2024 @RheumNow https://t.co/Hy4TmLzhzO
TheDaoIndex KDAO2011
2 years 8 months ago
"The link between RA and CVD is the shared inflammatory pathways involving IL-1, IL-6 and TNF" -Dr. B Weber #RNL2024 @rheumnow https://t.co/aGPA8ZFNHj
TheDaoIndex KDAO2011
2 years 8 months ago
CV disease risk is increased in patients with inflammatory rheumatic diseases. More data emerging in SLE, psoriasis, RA. – Dr. B Weber #RNL2024 @rheumnow https://t.co/wF9izGZug3
Eric Dein ericdeinmd
2 years 8 months ago
#RNL2024 @RheumNow
Weber:
Asymptomatic Lupus has higher rate of atherosclerosis at all age grps
35-44 yo F with SLE: 50X increased risk of MI compared to healthy pts in Framingham
RA pts at 1.5x risk of CVD https://t.co/TJ5dLXwvNc
Eric Dein ericdeinmd
2 years 8 months ago
#RNL2024 @RheumNow
Brittany Weber on Cardio-Rheumatology:
"Everything has changed" on inflammation and CVD
- Canakinumab 150 mg v PBO HR 0.85, p =0.02
- Colchicine v PBO HR 0.69, P<0.001
2023: FDA approval for colchicine as 1st anti-inflammatory for reducing CV events https://t.co/Tlv5Np2BHf
